Skip to main content
A

Ananda Pharma Plc — Investor Relations & Filings

Ticker · ANAN ISIN · GB00BDQPXQ60 LEI · 894500DFM8VOC5FW4X47 Aquis Stock Exchange Manufacturing
Open in API
Filings indexed 196 across all filing types
Latest filing 2023-03-09 Regulatory Filings
Country GB United Kingdom
Listing Aquis Stock Exchange ANAN

About Ananda Pharma Plc

https://www.anandapharma.co.uk/

Ananda Pharma Plc is a biopharmaceutical company focused on the development of regulatory-approved, cannabinoid-based medicines. The company's primary mission is to create therapies for complex, chronic inflammatory conditions with significant unmet medical needs. Its development pipeline is initially centered on treatments for inflammatory pain conditions, including Chemotherapy-Induced Peripheral Neuropathy (CIPN) and endometriosis, as well as heart failure with preserved ejection fraction (HFpEF). Ananda Pharma's approach covers the full development cycle, from identifying clinical potential and optimizing drug candidates to conducting clinical trials and securing marketing authorizations from regulators.

Recent filings

Filing Released Lang Actions
Ananda Developments Plc - Acquisition of MRX and Subscription
Regulatory Filings Classification · 95% confidence The document is a corporate announcement from Ananda Developments Plc regarding a proposed acquisition of MRX Medical, a capital raise via subscription, board changes, and the conversion of loan notes. It details the strategic rationale for the acquisition, the terms of the transaction, and the issuance of new equity. While it mentions a circular being sent to shareholders, the document itself is the primary announcement of these corporate actions (M&A and financing). Therefore, it is classified as M&A Activity (TAR) as it centers on the acquisition of MRX.
2023-03-09 English
Research Roundup
Regulatory Filings Classification · 98% confidence The document is a 'Medical Cannabis Research Roundup' issued by Ananda Developments PLC. It provides summaries of external research papers related to medical cannabis. It is distributed via the 'Reach' service, which is explicitly identified as a non-regulatory press release distribution service of the London Stock Exchange. Since it does not fit into specific financial reporting categories like 10-K, IR, or ER, and is a general corporate announcement/press release, it falls under the 'Regulatory Filings' (RNS) category as the designated fallback for miscellaneous regulatory-platform announcements.
2023-02-28 English
Research Roundup
Regulatory Filings Classification · 98% confidence The document is a 'Medical Cannabis Research Roundup' issued by Ananda Developments PLC. It summarizes scientific research articles related to cannabinoids and terpenes. It is distributed via the 'Reach' service, which is explicitly identified as a non-regulatory press release distribution service of the London Stock Exchange (RNS). Since it does not fit into specific financial reporting categories like 10-K, IR, or ER, and is a general corporate announcement/press release, it falls under the fallback category of Regulatory Filings (RNS).
2023-02-10 English
Ananda Developments Plc - Corporate Update
Regulatory Filings Classification · 95% confidence The document is a corporate update from Ananda Developments Plc regarding operational progress, specifically test results from cultivars, facility construction updates, and strain stabilization. It is distributed via PR Newswire and explicitly mentions it is an announcement containing inside information under the Market Abuse Regulation (MAR). It does not constitute a full financial report, earnings release, or proxy statement, but rather a general corporate update/regulatory announcement.
2023-02-06 English
Research Roundup
Regulatory Filings Classification · 98% confidence The document is a 'Medical Cannabis Research Roundup' issued by Ananda Developments PLC. It is distributed via the 'Reach' service, which is explicitly identified as a non-regulatory press release distribution service of the London Stock Exchange. The content is informational, summarizing scientific research papers rather than reporting on financial results, governance, or regulatory compliance. Since it does not fit into specific financial categories like 10-K, ER, or IR, and is a press release/news update, it falls under the 'Regulatory Filings' (RNS) category as the fallback for miscellaneous corporate announcements.
2023-01-05 English
Ananda Developments Plc - Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is a formal announcement regarding 'Total Voting Rights' issued by Ananda Developments Plc in accordance with the FCA's Disclosure and Transparency Rules. It provides the total number of shares and voting rights to assist shareholders in calculating their notification obligations. This type of regulatory disclosure regarding share capital and voting rights does not fit into specific categories like 'Major Shareholding Notification' (which is for individual investors) or 'Share Issue' (which is for the act of issuance). As it is a standard regulatory announcement required by the FCA, it falls under the 'Regulatory Filings' category.
2022-12-30 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.